Records containing: Mucopolysaccharidosis Type I
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-30Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
-
CLINICAL_TRIALS study record update · 2024-07-25A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 Given by a Single Intravenous Infusion in Patients With Mucopolysaccharidosis Type I
-
CLINICAL_TRIALS study record update · 2023-02-13Biomarker for Hurler Disease - An International, Multicenter, Epidemiological Protocol
-
CLINICAL_TRIALS study record update · 2019-11-01Magnetic Resonance Spectroscopy (MRS) to Determine Neuroinflammation and Oxidative Stress in MPS I
-
CLINICAL_TRIALS study record update · 2019-09-06Longitudinal Studies of Brain Structure and Function in MPS Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-12-13Behavioral Challenges in Children With Mucopolysaccharidosis Type I-III and Parental Coping Strategies
-
CLINICAL_TRIALS study record update · 2017-09-15Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI